{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:27:46Z","timestamp":1792124866036,"version":"4.4.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jilin Province Health Research Talents Special Project","award":["2024SCZ21"],"award-info":[{"award-number":["2024SCZ21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05290-w","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T11:16:30Z","timestamp":1764414990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Role of Thyroid Hormones in Neurodegenerative Disorders: Opportunities and Challenges"],"prefix":"10.1007","volume":"63","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"5290_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.14283\/jpad.2023.20","volume":"10","author":"A Salehipour","year":"2023","unstructured":"Salehipour A, Dolatshahi M, Haghshomar M, Amin J (2023) The role of thyroid dysfunction in Alzheimer's disease: a systematic review and meta-analysis. J Prev Alzheimers Dis 10:276\u2013286","journal-title":"J Prev Alzheimers Dis"},{"key":"5290_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fendo.2014.00040","volume":"5","author":"AC Schroeder","year":"2014","unstructured":"Schroeder AC, Privalsky ML (2014) Thyroid hormones, t3 and t4, in the brain. Front Endocrinol (Lausanne) 5:40","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5290_CR3","doi-asserted-by":"publisher","first-page":"E1238","DOI":"10.1152\/ajpendo.00480.2009","volume":"297","author":"PJ Davis","year":"2009","unstructured":"Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK (2009) Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 297:E1238\u2013E1246","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5290_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.114175","volume":"357","author":"H Chang","year":"2022","unstructured":"Chang H, Lin C, Li Z, Shen Y, Zhang G, Mao L, Ma C, Liu N, Lu H (2022) T3 alleviates neuroinflammation and reduces early brain injury after subarachnoid haemorrhage by promoting mitophagy via PINK 1-parkin pathway. Exp Neurol 357:114175","journal-title":"Exp Neurol"},{"key":"5290_CR5","doi-asserted-by":"crossref","unstructured":"B T, HK G (2018) Thyroid profile in drug naive cases of depression. J Depress Anxiety 7:1-5","DOI":"10.4172\/2167-1044.1000300"},{"key":"5290_CR6","first-page":"96","volume":"29","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liang Q, Han J (2025) Advances in research on the correlation between thyroid function and the prognosis of acute ischemic stroke. Chin J Exp Diagn 29:96\u2013100","journal-title":"Chin J Exp Diagn"},{"key":"5290_CR7","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1210\/en.2008-1572","volume":"150","author":"VA Galton","year":"2009","unstructured":"Galton VA, Schneider MJ, Clark AS, St Germain DL (2009) Life without thyroxine to 3,5,3'-triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases. Endocrinology 150:2957\u20132963","journal-title":"Endocrinology"},{"key":"5290_CR8","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1152\/jn.90801.2008","volume":"100","author":"MA Yonkers","year":"2008","unstructured":"Yonkers MA, Ribera AB (2008) Sensory neuron sodium current requires nongenomic actions of thyroid hormone during development. J Neurophysiol 100:2719\u20132725","journal-title":"J Neurophysiol"},{"key":"5290_CR9","unstructured":"Bernal J (2000) Thyroid hormones in brain development and function. In: Endotext (Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferr\u00e8re B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, eds). South Dartmouth (MA): MDText.com, Inc"},{"key":"5290_CR10","doi-asserted-by":"publisher","first-page":"14633","DOI":"10.1002\/jcp.28198","volume":"234","author":"K Bavarsad","year":"2019","unstructured":"Bavarsad K, Hosseini M, Hadjzadeh MA, Sahebkar A (2019) The effects of thyroid hormones on memory impairment and Alzheimer's disease. J Cell Physiol 234:14633\u201314640","journal-title":"J Cell Physiol"},{"key":"5290_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13293-021-00367-2","volume":"12","author":"S Baksi","year":"2021","unstructured":"Baksi S, Pradhan A (2021) Thyroid hormone: sex-dependent role in nervous system regulation and disease. Biol Sex Differ 12:25","journal-title":"Biol Sex Differ"},{"key":"5290_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.exger.2008.06.006","volume":"44","author":"L Fratiglioni","year":"2009","unstructured":"Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44:46\u201350","journal-title":"Exp Gerontol"},{"key":"5290_CR13","doi-asserted-by":"crossref","unstructured":"Zaib S, Javed H, Khan I, Jaber F, Sohail A, Zaib Z, Mehboob T, Tabassam N, Ogaly HA (2023) Neurodegenerative diseases: their onset, epidemiology, causes and treatment. Chemistryselect:8","DOI":"10.1002\/slct.202300225"},{"key":"5290_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/156720207781387204","volume":"4","author":"EA dos Reis-Lunardelli","year":"2007","unstructured":"dos Reis-Lunardelli EA, Castro CC, Bavaresco C, Coitinho AS, da Trindade LS, Perrenoud MF, Roesler R, Sarkis JJ, de Souza Wyse AT, Izquierdo I (2007) Effects of thyroid hormones on memory and on Na(+), K(+)-ATPase activity in rat brain. Curr Neurovasc Res 4:184\u2013193","journal-title":"Curr Neurovasc Res"},{"key":"5290_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1532-5415.1992.tb02130.x","volume":"40","author":"D Osterweil","year":"1992","unstructured":"Osterweil D, Syndulko K, Cohen SN, Pettler-Jennings PD, Hershman JM, Cummings JL, Tourtellotte WW, Solomon DH (1992) Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 40:325\u2013335","journal-title":"J Am Geriatr Soc"},{"key":"5290_CR16","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1210\/jc.2007-0011","volume":"92","author":"MH Samuels","year":"2007","unstructured":"Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS (2007) Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab 92:2545\u20132551","journal-title":"J Clin Endocrinol Metab"},{"key":"5290_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1212\/WNL.0000000000003227","volume":"87","author":"L Chaker","year":"2016","unstructured":"Chaker L, Wolters FJ, Bos D, Korevaar TI, Hofman A, van der Lugt A, Koudstaal PJ, Franco OH, Dehghan A, Vernooij MW, Peeters RP, Ikram MA (2016) Thyroid function and the risk of dementia: the Rotterdam study. Neurology 87:1688\u20131695","journal-title":"Neurology"},{"key":"5290_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000359966","volume":"38","author":"SM Choi","year":"2014","unstructured":"Choi SM, Kim BC, Choi KH, Nam TS, Kim JT, Lee SH, Park MS, Kim MK, Cho KH (2014) Thyroid status and cognitive function in euthyroid patients with early Parkinson's disease. Dement Geriatr Cogn Disord 38:178\u2013185","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5290_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/0006-3223(95)00489-0","volume":"40","author":"M Ganguli","year":"1996","unstructured":"Ganguli M, Burmeister LA, Seaberg EC, Belle S, DeKosky ST (1996) Association between dementia and elevated TSH: a community-based study. Biol Psychiatry 40:714\u2013725","journal-title":"Biol Psychiatry"},{"key":"5290_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-017-0291-5","volume":"9","author":"HJ Choi","year":"2017","unstructured":"Choi HJ, Byun MS, Yi D, Sohn BK, Lee JH, Lee JY, Kim YK, Lee DY (2017) Associations of thyroid hormone serum levels with in-vivo Alzheimer's disease pathologies. Alzheimers Res Ther 9:64","journal-title":"Alzheimers Res Ther"},{"key":"5290_CR21","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1212\/01.WNL.0000128134.84230.9F","volume":"62","author":"LA van Osch","year":"2004","unstructured":"van Osch LA, Hogervorst E, Combrinck M, Smith AD (2004) Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 62:1967\u20131971","journal-title":"Neurology"},{"key":"5290_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archinte.168.14.1514","volume":"168","author":"ZS Tan","year":"2008","unstructured":"Tan ZS, Beiser A, Vasan RS, Au R, Auerbach S, Kiel DP, Wolf PA, Seshadri S (2008) Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med 168:1514\u20131520","journal-title":"Arch Intern Med"},{"key":"5290_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.neurobiolaging.2007.07.019","volume":"30","author":"FJ de Jong","year":"2009","unstructured":"de Jong FJ, Masaki K, Chen H, Remaley AT, Breteler MM, Petrovitch H, White LR, Launer LJ (2009) Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study. Neurobiol Aging 30:600\u2013606","journal-title":"Neurobiol Aging"},{"key":"5290_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/1471-2458-10-298","volume":"10","author":"IM Bense\u00f1or","year":"2010","unstructured":"Bense\u00f1or IM, Lotufo PA, Menezes PR, Scazufca M (2010) Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH). BMC Public Health 10:298","journal-title":"BMC Public Health"},{"key":"5290_CR25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/hipo.22319","volume":"24","author":"A Chaalal","year":"2014","unstructured":"Chaalal A, Poirier R, Blum D, Gillet B, Le Blanc P, Basquin M, Bu\u00e9e L, Laroche S, Enderlin V (2014) PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments. Hippocampus 24:1381\u20131393","journal-title":"Hippocampus"},{"key":"5290_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135003","volume":"729","author":"LX Li","year":"2020","unstructured":"Li LX, Yang T, Guo L, Wang DY, Tang CH, Li Q, Yang HM, Zhu J, Zhang LL (2020) Serum tau levels are increased in patients with hyperthyroidism. Neurosci Lett 729:135003","journal-title":"Neurosci Lett"},{"key":"5290_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s12035-018-1111-z","volume":"56","author":"A Chaalal","year":"2019","unstructured":"Chaalal A, Poirier R, Blum D, Laroche S, Enderlin V (2019) Thyroid hormone supplementation restores spatial memory, hippocampal markers of neuroinflammation, plasticity-related signaling molecules, and \u03b2-amyloid peptide load in hypothyroid rats. Mol Neurobiol 56:722\u2013735","journal-title":"Mol Neurobiol"},{"key":"5290_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mce.2011.03.016","volume":"339","author":"M Belakavadi","year":"2011","unstructured":"Belakavadi M, Dell J, Grover GJ, Fondell JD (2011) Thyroid hormone suppression of \u03b2-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. Mol Cell Endocrinol 339:72\u201380","journal-title":"Mol Cell Endocrinol"},{"key":"5290_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1089\/thy.2006.16.1207","volume":"16","author":"SA O'Barr","year":"2006","unstructured":"O'Barr SA, Oh JS, Ma C, Brent GA, Schultz JJ (2006) Thyroid hormone regulates endogenous amyloid-beta precursor protein gene expression and processing in both in vitro and in vivo models. Thyroid 16:1207\u20131213","journal-title":"Thyroid"},{"key":"5290_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jdn.10220","volume":"82","author":"B Tan","year":"2022","unstructured":"Tan B, Babur E, Toy N, G\u00fcnayd\u0131n B, Dursun N, S\u00fcer C (2022) Tau protein is differentially phosphorylated in young- and old-aged rats with experimentally induced hyperthyroidism. Int J Dev Neurosci 82:654\u2013663","journal-title":"Int J Dev Neurosci"},{"key":"5290_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.lfs.2017.11.013","volume":"192","author":"F Prieto-Almeida","year":"2018","unstructured":"Prieto-Almeida F, Panveloski-Costa AC, Crunfli F, da Silva TS, Nunes MT, Torr\u00e3o ADS (2018) Thyroid hormone improves insulin signaling and reduces the activation of neurodegenerative pathway in the hippocampus of diabetic adult male rats. Life Sci 192:253\u2013258","journal-title":"Life Sci"},{"key":"5290_CR32","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s11011-022-01055-9","volume":"37","author":"AV Maglione","year":"2022","unstructured":"Maglione AV, BPP d N, Ribeiro MO, TJL d S, da Silva REC, Sato MA, CAA P, LRG B, de Souza JS, RMB M, da Concei\u00e7\u00e3o RR, Laureano-Melo R, Giannocco G (2022) Triiodothyronine treatment reverses depression-like behavior in a triple-transgenic animal model of Alzheimer's Disease. Metab Brain Dis 37:2735\u20132750","journal-title":"Metab Brain Dis"},{"key":"5290_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13195-024-01534-4","volume":"16","author":"JH Byeon","year":"2024","unstructured":"Byeon JH, Byun MS, Yi D, Jung JH, Sohn BK, Chang YY, Kong N, Jung G, Ahn H, Lee JY, Lee YS, Kim YK, Lee DY (2024) Moderation of thyroid hormones for the relationship between amyloid and tau pathology. Alzheimers Res Ther 16:164","journal-title":"Alzheimers Res Ther"},{"key":"5290_CR34","doi-asserted-by":"crossref","unstructured":"Peng Y, Zhu L, Bai Q, Wang L, Li Q (2024) Associations between thyroid hormones and cognitive impairment in patients with Parkinson's disease. eNeuro 11","DOI":"10.1523\/ENEURO.0239-24.2024"},{"key":"5290_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0306-4522(01)00229-9","volume":"105","author":"AE Kincaid","year":"2001","unstructured":"Kincaid AE (2001) Spontaneous circling behavior and dopamine neuron loss in a genetically hypothyroid mouse. Neuroscience 105:891\u2013898","journal-title":"Neuroscience"},{"key":"5290_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1353-8020(99)00010-3","volume":"5","author":"U Bonuccelli","year":"1999","unstructured":"Bonuccelli U, D'Avino C, Caraccio N, Del Guerra P, Casolaro A, Pavese N, Del Dotto P, Monzani F (1999) Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients. Parkinsonism Relat Disord 5:49\u201353","journal-title":"Parkinsonism Relat Disord"},{"key":"5290_CR37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jns.2017.08.2953","volume":"381","author":"T Umehara","year":"2017","unstructured":"Umehara T, Oka H, Nakahara A, Matsuno H, Toyoda C (2017) Serum free triiodothyronine in Parkinson's disease: a novel biomarker of weight variation and motor severity. J Neurol Sci 381:1045\u20131046","journal-title":"J Neurol Sci"},{"key":"5290_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000333222","volume":"10","author":"X Li","year":"2012","unstructured":"Li X, Sundquist J, Sundquist K (2012) Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener Dis 10:277\u2013284","journal-title":"Neurodegener Dis"},{"key":"5290_CR39","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","volume":"73","author":"K Rugbjerg","year":"2009","unstructured":"Rugbjerg K, Friis S, Ritz B, Schernhammer ES, Korbo L, Olsen JH (2009) Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology 73:1462\u20131468","journal-title":"Neurology"},{"key":"5290_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.etap.2012.12.008","volume":"35","author":"M Salama","year":"2013","unstructured":"Salama M, Helmy B, El-Gamal M, Reda A, Ellaithy A, Tantawy D, Mohamed M, El-Gamal A, Sheashaa H, Sobh M (2013) Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats. Environ Toxicol Pharmacol 35:270\u2013277","journal-title":"Environ Toxicol Pharmacol"},{"key":"5290_CR41","doi-asserted-by":"publisher","first-page":"13659","DOI":"10.1038\/s41598-019-49876-6","volume":"9","author":"EH Lee","year":"2019","unstructured":"Lee EH, Kim SM, Kim CH, Pagire SH, Pagire HS, Chung HY, Ahn JH, Park CH (2019) Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives. Sci Rep 9:13659","journal-title":"Sci Rep"},{"key":"5290_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.parkreldis.2005.01.009","volume":"11","author":"HT Kim","year":"2005","unstructured":"Kim HT, Edwards MJ, Lakshmi Narsimhan R, Bhatia KP (2005) Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson. Parkinsonism Relat Disord 11:331\u2013332","journal-title":"Parkinsonism Relat Disord"},{"key":"5290_CR43","doi-asserted-by":"crossref","unstructured":"Polini B, Ricardi C, Bertolini A, Carnicelli V, Rutigliano G, Saponaro F, Zucchi R, Chiellini G (2023) T1AM\/TAAR1 system reduces inflammatory response and \u03b2-amyloid toxicity in human microglial HMC3 cell line. Int J Mol Sci:24","DOI":"10.3390\/ijms241411569"},{"key":"5290_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolle E, Morin F, Bachoud-L\u00e9vi AC, Maison P (2009) Neuroendocrine disturbances in Huntington's disease. PLoS One 4:e4962","journal-title":"PLoS One"},{"key":"5290_CR45","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2265.2010.03836.x","volume":"73","author":"NA Aziz","year":"2010","unstructured":"Aziz NA, Pijl H, Fr\u00f6lich M, Roelfsema F, Roos RA (2010) Altered thyrotropic and lactotropic axes regulation in Huntington's disease. Clin Endocrinol (Oxf) 73:540\u2013545","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5290_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.114864","volume":"461","author":"F Badini","year":"2024","unstructured":"Badini F, Bayrami A, Mirshekar MA, Shahraki S, Fanaei H (2024) Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats. Behav Brain Res 461:114864","journal-title":"Behav Brain Res"},{"key":"5290_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0303-7207(02)00296-4","volume":"199","author":"SA Jones","year":"2003","unstructured":"Jones SA, Jolson DM, Cuta KK, Mariash CN, Anderson GW (2003) Triiodothyronine is a survival factor for developing oligodendrocytes. Mol Cell Endocrinol 199:49\u201360","journal-title":"Mol Cell Endocrinol"},{"key":"5290_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0303-7207(01)00592-5","volume":"184","author":"CC Wong","year":"2001","unstructured":"Wong CC, Leung MS (2001) Effects of neonatal hypothyroidism on the expressions of growth cone proteins and axon guidance molecules related genes in the hippocampus. Mol Cell Endocrinol 184:143\u2013150","journal-title":"Mol Cell Endocrinol"},{"key":"5290_CR49","doi-asserted-by":"publisher","first-page":"16363","DOI":"10.1073\/pnas.0407262101","volume":"101","author":"M Fernandez","year":"2004","unstructured":"Fernandez M, Giuliani A, Pirondi S, D'Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calz\u00e0 L (2004) Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A 101:16363\u201316368","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5290_CR50","doi-asserted-by":"crossref","unstructured":"Hung PL, Hsu MH, Yu HR, Wu KLH, Wang FS (2018) Thyroxin protects white matter from hypoxic-ischemic insult in the immature Sprague-Dawley rat brain by regulating periventricular white matter and cortex BDNF and CREB pathways. Int J Mol Sci 19","DOI":"10.3390\/ijms19092573"},{"key":"5290_CR51","doi-asserted-by":"publisher","first-page":"14189","DOI":"10.1523\/JNEUROSCI.4453-08.2008","volume":"28","author":"LA Harsan","year":"2008","unstructured":"Harsan LA, Steibel J, Zaremba A, Agin A, Sapin R, Poulet P, Guignard B, Parizel N, Grucker D, Boehm N, Miller RH, Ghandour MS (2008) Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J Neurosci 28:14189\u201314201","journal-title":"J Neurosci"},{"issue":"559-560","key":"5290_CR52","first-page":"562","volume":"51","author":"J K\u00f6hrle","year":"2010","unstructured":"K\u00f6hrle J, Brabant G (2010) Synthesis, metabolism and diagnostics of thyroid hormones. Internist (Berl) 51(559-560):562\u2013557","journal-title":"Internist (Berl)"},{"key":"5290_CR53","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1530\/JOE-21-0335","volume":"252","author":"I Ross","year":"2022","unstructured":"Ross I, Omengan DB, Huang GN, Payumo AY (2022) Thyroid hormone-dependent regulation of metabolism and heart regeneration. J Endocrinol 252:R71\u2013r82","journal-title":"J Endocrinol"},{"key":"5290_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fendo.2014.00040","volume":"5","author":"AC Schroeder","year":"2014","unstructured":"Schroeder AC, Privalsky ML (2014) Thyroid hormones, t3 and t4, in the brain. Front Endocrinol (Lausanne) 5:40","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5290_CR55","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1677\/JOE-07-0099","volume":"193","author":"MS Wagner","year":"2007","unstructured":"Wagner MS, Wajner SM, Dora JM, Maia AL (2007) Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient C3H mice. J Endocrinol 193:435\u2013444","journal-title":"J Endocrinol"},{"key":"5290_CR56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12020-019-01855-7","volume":"64","author":"A Harada","year":"2019","unstructured":"Harada A, Nomura E, Nishimura K, Ito M, Yoshida H, Miyauchi A, Nishikawa M, Shiojima I, Toyoda N (2019) Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with huge goitrous Hashimoto's thyroiditis. Endocrine 64:584\u2013590","journal-title":"Endocrine"},{"key":"5290_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fphys.2014.00402","volume":"5","author":"R Zucchi","year":"2014","unstructured":"Zucchi R, Accorroni A, Chiellini G (2014) Update on 3-iodothyronamine and its neurological and metabolic actions. Front Physiol 5:402","journal-title":"Front Physiol"},{"key":"5290_CR58","doi-asserted-by":"publisher","first-page":"40128","DOI":"10.1074\/jbc.M300909200","volume":"278","author":"EC Friesema","year":"2003","unstructured":"Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ (2003) Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128\u201340135","journal-title":"J Biol Chem"},{"key":"5290_CR59","doi-asserted-by":"crossref","unstructured":"Reinwald JR, Weber-Fahr W, Cosa-Linan A, Becker R, Sack M, Falfan-Melgoza C, Gass N, Braun U, Clemm von Hohenberg C, Chen J, Mayerl S, Muente TF, Heuer H, Sartorius A (2022) TRIAC treatment improves impaired brain network function and white matter loss in thyroid hormone transporter mct8\/oatp1c1 deficient mice. Int J Mol Sci:23","DOI":"10.3390\/ijms232415547"},{"key":"5290_CR60","first-page":"7-8+11","volume":"20","author":"D Li","year":"2013","unstructured":"Li D, Pang W, Xue L (2013) Study on the effects of thyroid hormone deficiency on glial cells during brain development. Contemporary Chinese Medicine (CCM) 20:7-8+11","journal-title":"Contemporary Chinese Medicine (CCM)"},{"key":"5290_CR61","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1172\/JCI70324","volume":"124","author":"S Mayerl","year":"2014","unstructured":"Mayerl S, M\u00fcller J, Bauer R, Richert S, Kassmann CM, Darras VM, Buder K, Boelen A, Visser TJ, Heuer H (2014) Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. J Clin Invest 124:1987\u20131999","journal-title":"J Clin Invest"},{"key":"5290_CR62","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mce.2017.05.023","volume":"452","author":"J Li","year":"2017","unstructured":"Li J, Donangelo I, Abe K, Scremin O, Ke S, Li F, Milanesi A, Liu YY, Brent GA (2017) Thyroid hormone treatment activates protective pathways in both in vivo and in vitro models of neuronal injury. Mol Cell Endocrinol 452:120\u2013130","journal-title":"Mol Cell Endocrinol"},{"key":"5290_CR63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1530\/eje.0.1330390","volume":"133","author":"J Bernal","year":"1995","unstructured":"Bernal J, Nunez J (1995) Thyroid hormones and brain development. Eur J Endocrinol 133:390\u2013398","journal-title":"Eur J Endocrinol"},{"key":"5290_CR64","first-page":"462","volume":"18","author":"JH Oppenheimer","year":"1997","unstructured":"Oppenheimer JH, Schwartz HL (1997) Molecular basis of thyroid hormone-dependent brain development. Endocr Rev 18:462\u2013475","journal-title":"Endocr Rev"},{"key":"5290_CR65","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1007\/s12035-023-03751-8","volume":"61","author":"S Salloum-Asfar","year":"2024","unstructured":"Salloum-Asfar S, Shin KC, Taha RZ, Khattak S, Park Y, Abdulla SA (2024) The potential role of thyroid hormone therapy in neural progenitor cell differentiation and its impact on neurodevelopmental disorders. Mol Neurobiol 61:3330\u20133342","journal-title":"Mol Neurobiol"},{"key":"5290_CR66","unstructured":"Genomics, circuits, and pathways in clinical neuropsychiatry. Elsevier Inc"},{"key":"5290_CR67","first-page":"729","volume":"21","author":"S Zeng","year":"2012","unstructured":"Zeng S, Su F (2012) Molecular biological effects of thyroid hormone deficiency on fetal brain development. Adv Obstet Gynecol 21:729\u2013731","journal-title":"Adv Obstet Gynecol"},{"key":"5290_CR68","first-page":"132","volume":"40","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Huang Q, Tang J, Zhong H, Zhang Q, Yang L, Ruan H, Wang Q (2024) Advances in the study of neural signaling pathways regulating myelin development in the central nervous system. J Neuroanat 40:132\u2013136","journal-title":"J Neuroanat"},{"key":"5290_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/35044547","volume":"1","author":"L Luo","year":"2000","unstructured":"Luo L (2000) Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1:173\u2013180","journal-title":"Nat Rev Neurosci"},{"key":"5290_CR70","unstructured":"Chen J, Song C (2008) The role of thyroid hormones in brain development and their clinical significance. Med Philos (Clinical Decision Forum Edition) 29:47-48+55"},{"key":"5290_CR71","first-page":"82","volume":"49","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang Z (2020) Functional and mechanistic studies of endogenous signaling pathways in neuronal axon regeneration. J Zhejiang Univ (Medical Edition) 49:82\u201389","journal-title":"J Zhejiang Univ (Medical Edition)"},{"key":"5290_CR72","first-page":"349","volume":"38","author":"H Gu","year":"2022","unstructured":"Gu H, Zhao J (2022) Structure, function, and role of myelin regulatory factors in related diseases. J Neuroanat 38:349\u2013353","journal-title":"J Neuroanat"},{"key":"5290_CR73","first-page":"617","volume":"39","author":"F Jing","year":"2023","unstructured":"Jing F, Juanfang W, Yanyu C, Anren Z (2023) Advances in the treatment of spinal cord injury targeting myelin sheaths. Chin J Pharmacol 39:617\u2013621","journal-title":"Chin J Pharmacol"},{"key":"5290_CR74","first-page":"36","volume":"18","author":"Y Ma","year":"2023","unstructured":"Ma Y, Kang W, Zhao K, Ma L, Dong W, Yu J (2023) Research progress on the association between environmental antibiotic concentrations causing anxiety\/depression-like behavior in zebrafish and the \u201cgut-brain\u201d pathway. J Ecotoxicol 18:36\u201355","journal-title":"J Ecotoxicol"},{"key":"5290_CR75","first-page":"3378","volume":"32","author":"M Lin","year":"2012","unstructured":"Lin M, Huang C, Liu Q, Cheng G (2012) Changes in hypothalamic-pituitary-thyroid axis hormone levels in patients with Alzheimer's disease. Chin J Gerontol 32:3378\u20133379","journal-title":"Chin J Gerontol"},{"key":"5290_CR76","first-page":"544","volume":"22","author":"F Wang","year":"2020","unstructured":"Wang F, Yan Z (2020) Advances in the Study of normal thyroid dysfunction syndrome. Chin J Med 22:544\u2013548","journal-title":"Chin J Med"},{"key":"5290_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell 18:e13031","journal-title":"Aging Cell"},{"key":"5290_CR78","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fendo.2018.00655","volume":"9","author":"LF Masullo","year":"2018","unstructured":"Masullo LF, Magalh\u00e3es RA, Lemes RPG, de Almeida Filho TP, de Castro MF, Maia Filho PA, Cunha TOV, Quidute ARP, Fontenele EGP, Sun G, Martins MRA (2018) Levothyroxine replacement improves oxidative status in primary hypothyroidism. Front Endocrinol (Lausanne) 9:655","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5290_CR79","first-page":"1204","volume":"50","author":"T Kang","year":"2021","unstructured":"Kang T, Zhu L, Cao B, Xue Y, Yang Q (2021) Mechanism of action of thyroid hormone receptor \u03b2 gene on \u03b2-amyloid 42-induced microglia inflammation and apoptosis. Shaanxi Medical Journal 50:1204\u20131209","journal-title":"Shaanxi Medical Journal"},{"key":"5290_CR80","first-page":"368","volume":"46","author":"L Yuan","year":"2020","unstructured":"Yuan L, Luan D, Yang Q, Zhou Z, Xu Y, Wang K (2020) Research progress on thyroid disease and cognitive impairment. Chin J Neuropsychiatry 46:368\u2013371","journal-title":"Chin J Neuropsychiatry"},{"key":"5290_CR81","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12020-011-9446-5","volume":"40","author":"I Kowalska","year":"2011","unstructured":"Kowalska I, Borawski J, Niko\u0142ajuk A, Budlewski T, Otziomek E, G\u00f3rska M, Str\u0105czkowski M (2011) Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine 40:95\u2013101","journal-title":"Endocrine"},{"key":"5290_CR82","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/cvr\/cvp304","volume":"85","author":"MA Carrillo-Sep\u00falveda","year":"2010","unstructured":"Carrillo-Sep\u00falveda MA, Ceravolo GS, Fortes ZB, Carvalho MH, Tostes RC, Laurindo FR, Webb RC, Barreto-Chaves ML (2010) Thyroid hormone stimulates NO production via activation of the PI3K\/Akt pathway in vascular myocytes. Cardiovasc Res 85:560\u2013570","journal-title":"Cardiovasc Res"},{"key":"5290_CR83","doi-asserted-by":"crossref","first-page":"92","DOI":"10.17116\/terarkh2014861292-97","volume":"86","author":"NM Platonova","year":"2014","unstructured":"Platonova NM, Sviridonova MA, Troshina EA (2014) Thyroid dysfunction and the hemostatic system. Ter Arkh 86:92\u201396","journal-title":"Ter Arkh"},{"key":"5290_CR84","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.neuropharm.2009.12.020","volume":"58","author":"AL Fu","year":"2010","unstructured":"Fu AL, Zhou CY, Chen X (2010) Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease. Neuropharmacology 58:722\u2013729","journal-title":"Neuropharmacology"},{"key":"5290_CR85","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.26510","volume":"93","author":"K Miyamoto","year":"2023","unstructured":"Miyamoto K, Saiki S, Matsumoto H, Suzuki A, Yamashita Y, Iseki T, Ueno SI, Shiina K, Kataura T, Kamagata K, Imamichi Y, Sasazawa Y, Fujimaki M, Akamatsu W, Hattori N (2023) Systemic metabolic alteration dependent on the thyroid-liver axis in early PD. Ann Neurol 93:303\u2013316","journal-title":"Ann Neurol"},{"key":"5290_CR86","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1523\/JNEUROSCI.22-17-07380.2002","volume":"22","author":"TD Stein","year":"2002","unstructured":"Stein TD, Johnson JA (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22:7380\u20137388","journal-title":"J Neurosci"},{"key":"5290_CR87","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40120-020-00217-0","volume":"9","author":"MA Liz","year":"2020","unstructured":"Liz MA, Coelho T, Bellotti V, Fernandez-Arias MI, Mallaina P, Obici L (2020) A narrative review of the role of transthyretin in health and disease. Neurol Ther 9:395\u2013402","journal-title":"Neurol Ther"},{"key":"5290_CR88","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2006.03.015","volume":"28","author":"JC Sousa","year":"2007","unstructured":"Sousa JC, Cardoso I, Marques F, Saraiva MJ, Palha JA (2007) Transthyretin and Alzheimer's disease: where in the brain? Neurobiol Aging 28:713\u2013718","journal-title":"Neurobiol Aging"},{"key":"5290_CR89","first-page":"318","volume":"63","author":"J Drzewi\u0144ska","year":"2009","unstructured":"Drzewi\u0144ska J, Pu\u0142aski L, Soszy\u0144ski M, Bartosz G (2009) Seladin-1\/DHCR24: a key protein of cell homeostasis and cholesterol biosynthesis. Postepy Hig Med Dosw (Online) 63:318\u2013330","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"5290_CR90","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0306-4522(02)00180-X","volume":"113","author":"S Iivonen","year":"2002","unstructured":"Iivonen S, Hiltunen M, Alafuzoff I, Mannermaa A, Kerokoski P, Puoliv\u00e4li J, Salminen A, Helisalmi S, Soininen H (2002) Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 113:301\u2013310","journal-title":"Neuroscience"},{"key":"5290_CR91","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1523\/JNEUROSCI.20-19-07345.2000","volume":"20","author":"I Greeve","year":"2000","unstructured":"Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2000) The human DIMINUTO\/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345\u20137352","journal-title":"J Neurosci"},{"key":"5290_CR92","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1677\/JOE-07-0324","volume":"197","author":"S Benvenuti","year":"2008","unstructured":"Benvenuti S, Luciani P, Cellai I, Deledda C, Baglioni S, Saccardi R, Urbani S, Francini F, Squecco R, Giuliani C, Vannelli GB, Serio M, Pinchera A, Peri A (2008) Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. J Endocrinol 197:437\u2013446","journal-title":"J Endocrinol"},{"key":"5290_CR93","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fnmol.2011.00029","volume":"4","author":"HY Lin","year":"2011","unstructured":"Lin HY, Davis FB, Luidens MK, Mousa SA, Cao JH, Zhou M, Davis PJ (2011) Molecular basis for certain neuroprotective effects of thyroid hormone. Front Mol Neurosci 4:29","journal-title":"Front Mol Neurosci"},{"key":"5290_CR94","doi-asserted-by":"publisher","first-page":"1354372","DOI":"10.3389\/fendo.2024.1354372","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Liu J (2024) Thyroid dysfunction and Alzheimer's disease, a vicious circle. Front Endocrinol (Lausanne) 15:1354372","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5290_CR95","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","volume":"27","author":"D Kaur","year":"2019","unstructured":"Kaur D, Sharma V, Deshmukh R (2019) Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease. Inflammopharmacology 27:663\u2013677","journal-title":"Inflammopharmacology"},{"key":"5290_CR96","doi-asserted-by":"publisher","first-page":"416","DOI":"10.23736\/S0390-5616.16.03431-7","volume":"61","author":"P Zheng","year":"2017","unstructured":"Zheng P, Tong W (2017) IGF-1: an endogenous link between traumatic brain injury and Alzheimer disease? J Neurosurg Sci 61:416\u2013421","journal-title":"J Neurosurg Sci"},{"key":"5290_CR97","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","volume":"30","author":"Z Chen","year":"2014","unstructured":"Chen Z, Zhong C (2014) Oxidative stress in Alzheimer's disease. Neurosci Bull 30:271\u2013281","journal-title":"Neurosci Bull"},{"key":"5290_CR98","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11011-021-00760-1","volume":"36","author":"PBS Figueroa","year":"2021","unstructured":"Figueroa PBS, Ferreira AFF, Britto LR, Doussoulin AP, Torr\u00e3o ADS (2021) Association between thyroid function and Alzheimer's disease: a systematic review. Metab Brain Dis 36:1523\u20131543","journal-title":"Metab Brain Dis"},{"key":"5290_CR99","doi-asserted-by":"publisher","first-page":"30366","DOI":"10.1074\/jbc.273.46.30366","volume":"273","author":"B Belandia","year":"1998","unstructured":"Belandia B, Latasa MJ, Villa A, Pascual A (1998) Thyroid hormone negatively regulates the transcriptional activity of the beta-amyloid precursor protein gene. J Biol Chem 273:30366\u201330371","journal-title":"J Biol Chem"},{"key":"5290_CR100","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/hipo.22319","volume":"24","author":"A Chaalal","year":"2014","unstructured":"Chaalal A, Poirier R, Blum D, Gillet B, Le Blanc P, Basquin M, Bu\u00e9e L, Laroche S, Enderlin V (2014) PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments. Hippocampus 24:1381\u20131393","journal-title":"Hippocampus"},{"key":"5290_CR101","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.devbrainres.2004.10.005","volume":"154","author":"GW Calloni","year":"2005","unstructured":"Calloni GW, Penno CA, Cordova FM, Trentin AG, Neto VM, Leal RB (2005) Congenital hypothyroidism alters the phosphorylation of ERK1\/2 and p38MAPK in the hippocampus of neonatal rats. Brain Res Dev Brain Res 154:141\u2013145","journal-title":"Brain Res Dev Brain Res"},{"key":"5290_CR102","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1523\/JNEUROSCI.20-11-03937.2000","volume":"20","author":"HM Tucker","year":"2000","unstructured":"Tucker HM, Kihiko M, Caldwell JN, Wright S, Kawarabayashi T, Price D, Walker D, Scheff S, McGillis JP, Rydel RE, Estus S (2000) The plasmin system is induced by and degrades amyloid-beta aggregates. J Neurosci 20:3937\u20133946","journal-title":"J Neurosci"},{"key":"5290_CR103","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.neuint.2013.08.010","volume":"63","author":"B Subhadra","year":"2013","unstructured":"Subhadra B, Schaller K, Seeds NW (2013) Neuroserpin up-regulation in the Alzheimer's disease brain is associated with elevated thyroid hormone receptor-\u03b21 and HuD expression. Neurochem Int 63:476\u2013481","journal-title":"Neurochem Int"},{"key":"5290_CR104","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1089\/thy.2019.0727","volume":"30","author":"BW Choi","year":"2020","unstructured":"Choi BW, Kim S, Kang S, Won KS, Yi HA, Kim HW (2020) Relationship between thyroid hormone levels and the pathology of Alzheimer's disease in euthyroid subjects. Thyroid 30:1547\u20131555","journal-title":"Thyroid"},{"key":"5290_CR105","first-page":"216","volume":"44","author":"DO Alamara","year":"2023","unstructured":"Alamara DO, Sadeghi L, Dehghan G (2023) The relationship between thyroid deficiency and blood-based biomarkers of cognitive disorders. Neuro Endocrinol Lett 44:216\u2013222","journal-title":"Neuro Endocrinol Lett"},{"key":"5290_CR106","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00213-009-1499-2","volume":"204","author":"HB Lin","year":"2009","unstructured":"Lin HB, Yang XM, Li TJ, Cheng YF, Zhang HT, Xu JP (2009) Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer's disease. Psychopharmacology (Berl) 204:705\u2013714","journal-title":"Psychopharmacology (Berl)"},{"key":"5290_CR107","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O et al (2015) Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study. Alzheimers Dement 11:964\u2013974","journal-title":"Alzheimers Dement"},{"key":"5290_CR108","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1365-2826.2008.01774.x","volume":"20","author":"M Bauer","year":"2008","unstructured":"Bauer M, Goetz T, Glenn T, Whybrow PC (2008) The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 20:1101\u20131114","journal-title":"J Neuroendocrinol"},{"key":"5290_CR109","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1365-2265.2007.02907.x","volume":"67","author":"A Iervasi","year":"2007","unstructured":"Iervasi A, Iervasi G, Ferdeghini M, Solimeo C, Bottoni A, Rossi L, Colato C, Zucchelli GC (2007) Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf) 67:434\u2013441","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5290_CR110","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1210\/jc.2010-2693","volume":"96","author":"T Vadiveloo","year":"2011","unstructured":"Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011) The thyroid epidemiology, audit, and research study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96:1344\u20131351","journal-title":"J Clin Endocrinol Metab"},{"key":"5290_CR111","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ecl.2014.02.006","volume":"43","author":"MH Samuels","year":"2014","unstructured":"Samuels MH (2014) Thyroid disease and cognition. Endocrinol Metab Clin North Am 43:529\u2013543","journal-title":"Endocrinol Metab Clin North Am"},{"key":"5290_CR112","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MED.0000000000000089","volume":"21","author":"MH Samuels","year":"2014","unstructured":"Samuels MH (2014) Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes 21:377\u2013383","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"5290_CR113","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.30773\/pi.2020.0182","volume":"17","author":"B Kim","year":"2020","unstructured":"Kim B, Moon SW (2020) Association between thyroid hormones, apolipoprotein e, and cognitive function among cognitively-normal elderly dwellers. Psychiatry Investig 17:1006\u20131012","journal-title":"Psychiatry Investig"},{"key":"5290_CR114","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fmed.2020.00298","volume":"7","author":"JS Lee","year":"2020","unstructured":"Lee JS, Soh Y, Kim HG, Lee KM, Kwon YN, Yoon SS, Park KC, Rhee HY (2020) Interactive effects of apolipoprotein e \u03b54 and triiodothyronine on memory performance in patients with subjective cognitive decline. Front Med (Lausanne) 7:298","journal-title":"Front Med (Lausanne)"},{"key":"5290_CR115","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3233\/JAD-2004-6510","volume":"6","author":"L Luo","year":"2004","unstructured":"Luo L, Stopa EG (2004) Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons. J Alzheimers Dis 6:527\u2013536","journal-title":"J Alzheimers Dis"},{"key":"5290_CR116","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114\u2013131","journal-title":"Pharmacol Ther"},{"key":"5290_CR117","doi-asserted-by":"publisher","first-page":"C355","DOI":"10.1152\/ajpcell.00415.2007","volume":"296","author":"KJ Menzies","year":"2009","unstructured":"Menzies KJ, Robinson BH, Hood DA (2009) Effect of thyroid hormone on mitochondrial properties and oxidative stress in cells from patients with mtDNA defects. Am J Physiol Cell Physiol 296:C355\u2013C362","journal-title":"Am J Physiol Cell Physiol"},{"key":"5290_CR118","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mce.2014.04.010","volume":"391","author":"AL de Castro","year":"2014","unstructured":"de Castro AL, Tavares AV, Campos C, Fernandes RO, Siqueira R, Conzatti A, Bicca AM, Fernandes TR, Sart\u00f3rio CL, Schenkel PC, Bell\u00f3-Klein A, da Rosa Araujo AS (2014) Cardioprotective effects of thyroid hormones in a rat model of myocardial infarction are associated with oxidative stress reduction. Mol Cell Endocrinol 391:22\u201329","journal-title":"Mol Cell Endocrinol"},{"key":"5290_CR119","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.metabol.2013.05.008","volume":"62","author":"I Mourouzis","year":"2013","unstructured":"Mourouzis I, Giagourta I, Galanopoulos G, Mantzouratou P, Kostakou E, Kokkinos AD, Tentolouris N, Pantos C (2013) Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt\/mTOR and AMPK activation. Metabolism 62:1387\u20131393","journal-title":"Metabolism"},{"key":"5290_CR120","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1582-4934.2010.01014.x","volume":"15","author":"F Forini","year":"2011","unstructured":"Forini F, Lionetti V, Ardehali H, Pucci A, Cecchetti F, Ghanefar M, Nicolini G, Ichikawa Y, Nannipieri M, Recchia FA, Iervasi G (2011) Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats. J Cell Mol Med 15:514\u2013524","journal-title":"J Cell Mol Med"},{"key":"5290_CR121","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333\u2013344","journal-title":"Nat Rev Neurosci"},{"key":"5290_CR122","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2147\/NDT.S84266","volume":"11","author":"VV Giau","year":"2015","unstructured":"Giau VV, Bagyinszky E, An SS, Kim SY (2015) Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat 11:1723\u20131737","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5290_CR123","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X (2025) Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 16:83\u2013120","journal-title":"Protein Cell"},{"key":"5290_CR124","doi-asserted-by":"crossref","unstructured":"Runfola M, Perni M, Yang X, Marchese M, Bacci A, Mero S, Santorelli FM, Polini B, Chiellini G, Giuliani D, Vilella A, Bodria M, Daini E, Vandini E, Rudge S, Gul S, Wakelam MOJ, Vendruscolo M, Rapposelli S (2021) Identification of a thyroid hormone derivative as a pleiotropic agent for the treatment of Alzheimer's disease. Pharmaceuticals (Basel) 14","DOI":"10.3390\/ph14121330"},{"key":"5290_CR125","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/thy.2019.0255","volume":"30","author":"A Accorroni","year":"2020","unstructured":"Accorroni A, Rutigliano G, Sabatini M, Frascarelli S, Bors\u00f2 M, Novelli E, Bandini L, Ghelardoni S, Saba A, Zucchi R, Origlia N (2020) Exogenous 3-iodothyronamine rescues the entorhinal cortex from \u03b2-amyloid toxicity. Thyroid 30:147\u2013160","journal-title":"Thyroid"},{"key":"5290_CR126","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson's disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"key":"5290_CR127","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.pmbts.2020.11.001","volume":"177","author":"G Forloni","year":"2021","unstructured":"Forloni G, La Vitola P, Cerovic M, Balducci C (2021) Inflammation and Parkinson's disease pathogenesis: mechanisms and therapeutic insight. Prog Mol Biol Transl Sci 177:175\u2013202","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5290_CR128","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-12-398314-5.00004-0","volume":"88","author":"KU Tufekci","year":"2012","unstructured":"Tufekci KU, Meuwissen R, Genc S, Genc K (2012) Inflammation in Parkinson's disease. Adv Protein Chem Struct Biol 88:69\u2013132","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"Suppl 1","key":"5290_CR129","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jnc.13062","volume":"136","author":"Z Chen","year":"2016","unstructured":"Chen Z, Trapp BD (2016) Microglia and neuroprotection. J Neurochem 136(Suppl 1):10\u201317","journal-title":"J Neurochem"},{"key":"5290_CR130","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.15684","volume":"179","author":"ME Haque","year":"2022","unstructured":"Haque ME, Akther M, Azam S, Kim IS, Lin Y, Lee YH, Choi DK (2022) Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease. Br J Pharmacol 179:23\u201345","journal-title":"Br J Pharmacol"},{"key":"5290_CR131","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","volume":"102","author":"FM Sacks","year":"2000","unstructured":"Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E (2000) VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 102:1886\u20131892","journal-title":"Circulation"},{"key":"5290_CR132","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1515\/cclm.2002.198","volume":"40","author":"U Resch","year":"2002","unstructured":"Resch U, Helsel G, Tatzber F, Sinzinger H (2002) Antioxidant status in thyroid dysfunction. Clin Chem Lab Med 40:1132\u20131134","journal-title":"Clin Chem Lab Med"},{"key":"5290_CR133","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1677\/joe.0.1760031","volume":"176","author":"N Petrovi\u0107","year":"2003","unstructured":"Petrovi\u0107 N, Cviji\u0107 G, Davidovi\u0107 V (2003) Thyroxine and tri-iodothyronine differently affect uncoupling protein-1 content and antioxidant enzyme activities in rat interscapular brown adipose tissue. J Endocrinol 176:31\u201338","journal-title":"J Endocrinol"},{"key":"5290_CR134","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12020-012-9849-y","volume":"44","author":"A Haribabu","year":"2013","unstructured":"Haribabu A, Reddy VS, Pallavi C, Bitla AR, Sachan A, Pullaiah P, Suresh V, Rao PV, Suchitra MM (2013) Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine 44:152\u2013157","journal-title":"Endocrine"},{"key":"5290_CR135","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27:9220\u20139232","journal-title":"J Neurosci"},{"key":"5290_CR136","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","volume":"15","author":"A De Virgilio","year":"2016","unstructured":"De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A, Conte M, Rosato C, Ciniglio Appiani M, de Vincentiis M (2016) Parkinson's disease: autoimmunity and neuroinflammation. Autoimmun Rev 15:1005\u20131011","journal-title":"Autoimmun Rev"},{"key":"5290_CR137","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1177\/0300060518816873","volume":"47","author":"S Delhasse","year":"2019","unstructured":"Delhasse S, Debove I, Arnold-Kunz G, Ghika JA, Chabwine JN (2019) Erratic movement disorders disclosing Graves' disease and paralleling thyroid function but not autoantibody levels. J Int Med Res 47:1378\u20131386","journal-title":"J Int Med Res"},{"key":"5290_CR138","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1326-9-47","volume":"9","author":"JQ Li","year":"2014","unstructured":"Li JQ, Tan L, Yu JT (2014) The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener 9:47","journal-title":"Mol Neurodegener"},{"key":"5290_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2013.01.011","volume":"537","author":"EM Gatto","year":"2013","unstructured":"Gatto EM, Parisi V, Converso DP, Poderoso JJ, Carreras MC, Mart\u00ed-Mass\u00f3 JF, Pais\u00e1n-Ruiz C (2013) The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics. Neurosci Lett 537:1\u20135","journal-title":"Neurosci Lett"},{"key":"5290_CR140","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neuroscience.2018.05.027","volume":"384","author":"F Napolitano","year":"2018","unstructured":"Napolitano F, D'Angelo L, de Girolamo P, Avallone L, de Lange P, Usiello A (2018) The thyroid hormone-target gene Rhes a novel crossroad for neurological and psychiatric disorders: new insights from animal models. Neuroscience 384:419\u2013428","journal-title":"Neuroscience"},{"key":"5290_CR141","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0140-6736(88)92677-3","volume":"2","author":"B Verges","year":"1988","unstructured":"Verges B, Giroud M, Richard A, Giroud-Baleydier F, Vaillant G, Lorcerie B, Brun JM, Putelat R (1988) Parkinson's disease after antithyroid treatment. Lancet 2:564","journal-title":"Lancet"},{"key":"5290_CR142","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000114600","volume":"12","author":"S Lavy","year":"1974","unstructured":"Lavy S, Marks ES, Abramsky O (1974) Parkinsonism and hyperthyroidism. Eur Neurol 12:20\u201327","journal-title":"Eur Neurol"},{"key":"5290_CR143","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fncel.2018.00417","volume":"12","author":"C Zheng","year":"2018","unstructured":"Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J, Cheng C, Yang X, Nie S, Xu Y, Zhang Z, Papa SM, Ye K, Cao X (2018) TRH analog, Taltirelin improves motor function of hemi-PD rats without inducing dyskinesia via sustained dopamine stimulating effect. Front Cell Neurosci 12:417","journal-title":"Front Cell Neurosci"},{"key":"5290_CR144","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3389\/fendo.2019.00631","volume":"10","author":"M Brokhin","year":"2019","unstructured":"Brokhin M, Danzi S, Klein I (2019) Assessment of the adequacy of thyroid hormone replacement therapy in hypothyroidism. Front Endocrinol (Lausanne) 10:631","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5290_CR145","doi-asserted-by":"publisher","first-page":"1204842","DOI":"10.3389\/fendo.2023.1204842","volume":"14","author":"I Lieber","year":"2023","unstructured":"Lieber I, Van Der Feltz-Cornelis CM, Razvi S, Moriarty AS, Wilkes S, Ott M, Mannchen J, Eliasson M, Werneke U (2023) Treating subclinical hypothyroidism in individuals with or without mental health problems -A Delphi based expert consensus study in two countries. Front Endocrinol (Lausanne) 14:1204842","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5290_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138848","volume":"10","author":"E Kalliolia","year":"2015","unstructured":"Kalliolia E, Silajd\u017ei\u0107 E, Nambron R, Costelloe SJ, Martin NG, Hill NR, Frost C, Watt HC, Hindmarsh P, Bj\u00f6rkqvist M, Warner TT (2015) A 24-hour study of the hypothalamo-pituitary axes in Huntington's disease. PLoS One 10:e0138848","journal-title":"PLoS One"},{"key":"5290_CR147","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1007\/s12010-021-03523-x","volume":"193","author":"P Talukder","year":"2021","unstructured":"Talukder P, Jana A, Dhar S, Ghosh S (2021) Huntington's chorea-a rare neurodegenerative autosomal dominant disease: insight into molecular genetics, prognosis and diagnosis. Appl Biochem Biotechnol 193:2634\u20132648","journal-title":"Appl Biochem Biotechnol"},{"key":"5290_CR148","doi-asserted-by":"crossref","unstructured":"Tassone A, Meringolo M, Ponterio G, Bonsi P, Schirinzi T, Martella G (2023) Mitochondrial bioenergy in neurodegenerative disease: Huntington and Parkinson. Int J Mol Sci 24","DOI":"10.20944\/preprints202303.0484.v1"},{"key":"5290_CR149","doi-asserted-by":"publisher","first-page":"8653132","DOI":"10.1155\/2016\/8653132","volume":"2016","author":"NP Rocha","year":"2016","unstructured":"Rocha NP, Ribeiro FM, Furr-Stimming E, Teixeira AL (2016) Neuroimmunology of Huntington's disease: revisiting evidence from human studies. Mediators Inflamm 2016:8653132","journal-title":"Mediators Inflamm"},{"key":"5290_CR150","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13311-023-01357-5","volume":"20","author":"M Cvetanovic","year":"2023","unstructured":"Cvetanovic M, Gray M (2023) Contribution of glial cells to polyglutamine diseases: observations from patients and mouse models. Neurotherapeutics 20:48\u201366","journal-title":"Neurotherapeutics"},{"key":"5290_CR151","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/jc.2014-4092","volume":"100","author":"EA McAninch","year":"2015","unstructured":"McAninch EA, Jo S, Preite NZ, Farkas E, Moh\u00e1csik P, Fekete C, Egri P, Gereben B, Li Y, Deng Y, Patti ME, Zevenbergen C, Peeters RP, Mash DC, Bianco AC (2015) Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. J Clin Endocrinol Metab 100:920\u2013933","journal-title":"J Clin Endocrinol Metab"},{"key":"5290_CR152","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/hmg\/ddu571","volume":"24","author":"L Francelle","year":"2015","unstructured":"Francelle L, Galvan L, Gaillard MC, Guillermier M, Houitte D, Bonvento G, Petit F, Jan C, Dufour N, Hantraye P, Elalouf JM, De Chald\u00e9e M, D\u00e9glon N, Brouillet E (2015) Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Hum Mol Genet 24:1563\u20131573","journal-title":"Hum Mol Genet"},{"key":"5290_CR153","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10048-003-0169-5","volume":"5","author":"A van Dellen","year":"2004","unstructured":"van Dellen A, Hannan AJ (2004) Genetic and environmental factors in the pathogenesis of Huntington's disease. Neurogenetics 5:9\u201317","journal-title":"Neurogenetics"},{"key":"5290_CR154","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3934\/Neuroscience.2024005","volume":"11","author":"U Ansari","year":"2024","unstructured":"Ansari U, Nadora D, Alam M, Wen J, Asad S, Lui F (2024) Influence of dietary patterns in the pathophysiology of Huntington's disease: A literature review. AIMS Neurosci 11:63\u201375","journal-title":"AIMS Neurosci"},{"key":"5290_CR155","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523\u20131631","journal-title":"Physiol Rev"},{"key":"5290_CR156","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/10408440601123446","volume":"37","author":"RT Zoeller","year":"2007","unstructured":"Zoeller RT, Tan SW, Tyl RW (2007) General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol 37:11\u201353","journal-title":"Crit Rev Toxicol"},{"key":"5290_CR157","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(77)90608-0","volume":"2","author":"MR Hayden","year":"1977","unstructured":"Hayden MR, Vinik AI, Paul M, Beighton P (1977) Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess. Lancet 2:423\u2013426","journal-title":"Lancet"},{"key":"5290_CR158","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuroscience.2012.11.022","volume":"239","author":"ME Gilbert","year":"2013","unstructured":"Gilbert ME, Lasley SM (2013) Developmental thyroid hormone insufficiency and brain development: a role for brain-derived neurotrophic factor (BDNF)? Neuroscience 239:253\u2013270","journal-title":"Neuroscience"},{"key":"5290_CR159","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/105072501750159534","volume":"11","author":"N Koibuchi","year":"2001","unstructured":"Koibuchi N, Yamaoka S, Chin WW (2001) Effect of altered thyroid status on neurotrophin gene expression during postnatal development of the mouse cerebellum. Thyroid 11:205\u2013210","journal-title":"Thyroid"},{"key":"5290_CR160","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0304-3940(03)00880-2","volume":"350","author":"D Camboni","year":"2003","unstructured":"Camboni D, Roskoden T, Schwegler H (2003) Effect of early thyroxine treatment on brain-derived neurotrophic factor mRNA expression and protein amount in the rat medial septum\/diagonal band of Broca. Neurosci Lett 350:141\u2013144","journal-title":"Neurosci Lett"},{"key":"5290_CR161","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2013.10.057","volume":"720","author":"A Kumar","year":"2013","unstructured":"Kumar A, Chaudhary T, Mishra J (2013) Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences. Eur J Pharmacol 720:16\u201328","journal-title":"Eur J Pharmacol"},{"key":"5290_CR162","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/WCO.0000000000000319","volume":"29","author":"PP Axisa","year":"2016","unstructured":"Axisa PP, Hafler DA (2016) Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol 29:345\u2013353","journal-title":"Curr Opin Neurol"},{"key":"5290_CR163","doi-asserted-by":"publisher","first-page":"1010304","DOI":"10.3389\/fimmu.2022.1010304","volume":"13","author":"M Melnikov","year":"2022","unstructured":"Melnikov M, Lopatina A (2022) Th17-cells in depression: Implication in multiple sclerosis. Front Immunol 13:1010304","journal-title":"Front Immunol"},{"key":"5290_CR164","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2010.0429","volume":"21","author":"P De Vito","year":"2011","unstructured":"De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ (2011) Thyroid hormones as modulators of immune activities at the cellular level. Thyroid 21:879\u2013890","journal-title":"Thyroid"},{"key":"5290_CR165","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1002\/jcp.22681","volume":"226","author":"ML Barreiro Arcos","year":"2011","unstructured":"Barreiro Arcos ML, Sterle HA, Paulazo MA, Valli E, Klecha AJ, Isse B, Pellizas CG, Farias RN, Cremaschi GA (2011) Cooperative nongenomic and genomic actions on thyroid hormone mediated-modulation of T cell proliferation involve up-regulation of thyroid hormone receptor and inducible nitric oxide synthase expression. J Cell Physiol 226:3208\u20133218","journal-title":"J Cell Physiol"},{"key":"5290_CR166","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0006-8993(96)01480-1","volume":"752","author":"N Ibarrola","year":"1997","unstructured":"Ibarrola N, Rodr\u00edguez-Pe\u00f1a A (1997) Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development. Brain Res 752:285\u2013293","journal-title":"Brain Res"},{"key":"5290_CR167","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI116301","volume":"91","author":"A Rodriguez-Pe\u00f1a","year":"1993","unstructured":"Rodriguez-Pe\u00f1a A, Ibarrola N, I\u00f1iguez MA, Mu\u00f1oz A, Bernal J (1993) Neonatal hypothyroidism affects the timely expression of myelin-associated glycoprotein in the rat brain. J Clin Invest 91:812\u2013818","journal-title":"J Clin Invest"},{"key":"5290_CR168","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839\u2013855","journal-title":"Nat Rev Neurosci"},{"key":"5290_CR169","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0083-6729(05)71004-9","volume":"71","author":"J Bernal","year":"2005","unstructured":"Bernal J (2005) Thyroid hormones and brain development. Vitam Horm 71:95\u2013122","journal-title":"Vitam Horm"},{"key":"5290_CR170","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1073\/pnas.052704499","volume":"99","author":"L Calza","year":"2002","unstructured":"Calza L, Fernandez M, Giuliani A, Aloe L, Giardino L (2002) Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A 99:3258\u20133263","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5290_CR171","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/WCO.0b013e32830f1e50","volume":"21","author":"F Sher","year":"2008","unstructured":"Sher F, Balasubramaniyan V, Boddeke E, Copray S (2008) Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy. Curr Opin Neurol 21:607\u2013614","journal-title":"Curr Opin Neurol"},{"key":"5290_CR172","doi-asserted-by":"crossref","unstructured":"Kotter MR, Stadelmann C, Hartung HP (2011) Enhancing remyelination in disease--can we wrap it up? Brain 134:1882-1900","DOI":"10.1093\/brain\/awr014"},{"key":"5290_CR173","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3389\/fnins.2020.00875","volume":"14","author":"P Vancamp","year":"2020","unstructured":"Vancamp P, Butruille L, Demeneix BA, Remaud S (2020) Thyroid hormone and neural stem cells: repair potential following brain and spinal cord injury. Front Neurosci 14:875","journal-title":"Front Neurosci"},{"key":"5290_CR174","first-page":"1","volume":"59","author":"C Qiu","year":"2021","unstructured":"Qiu C, Zhang Y, Chen S, Shao L, Mei X, Zhou D (2021) A study on thyroid function in patients with different stages of Alzheimer's disease. Chinese Modern Doctor 59:1\u20135","journal-title":"Chinese Modern Doctor"},{"key":"5290_CR175","volume-title":"Diabetes, Alzheimer's disease risk factors, and the cafeteria diet: a comprehensive review","author":"M Abubakar","year":"2025","unstructured":"Abubakar M, Giri A, Goel F, Khan M, Gupta J, Kumar D, Kaushik M, Rai SN, Kumar N (2025) Diabetes, Alzheimer's disease risk factors, and the cafeteria diet: a comprehensive review. Curr Neuropharmacol"},{"key":"5290_CR176","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ejn.16215","volume":"59","author":"L M\u00e9sz\u00e1ros","year":"2024","unstructured":"M\u00e9sz\u00e1ros L, Himmler M, Schneider Y, Arnold P, D\u00f6rje F, Schubert DW, Winkler J (2024) Sobetirome rescues \u03b1-synuclein-mediated demyelination in an in vitro model of multiple system atrophy. Eur J Neurosci 59:308\u2013315","journal-title":"Eur J Neurosci"},{"key":"5290_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115227","volume":"389","author":"ID Duncan","year":"2025","unstructured":"Duncan ID, Vivian JA, August BK, Keuler NS, Komro A, Radecki D, Kiland JA, Gandhi R, Reilly M, Cameron S, Rylander H, Pritchard J, Ver Hoeve JN (2025) Promotion of remyelination by a thyromimetic drug leading to functional recovery. Exp Neurol 389:115227","journal-title":"Exp Neurol"},{"key":"5290_CR178","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s13311-023-01402-3","volume":"20","author":"SD Newsome","year":"2023","unstructured":"Newsome SD, Tian F, Shoemaker T, Fitzgerald KC, Cassard SD, Fiol J, Snoops S, Cooper DS, Mammen JSR, Bhargava P, Mowry EM, Calabresi PA (2023) A phase 1b, open-label study to evaluate the safety and tolerability of the putative remyelinating agent, liothyronine, in individuals with MS. Neurotherapeutics 20:1263\u20131274","journal-title":"Neurotherapeutics"},{"key":"5290_CR179","doi-asserted-by":"publisher","first-page":"5496891","DOI":"10.1155\/2019\/5496891","volume":"2019","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Petratos S (2019) Oligodendroglial lineage cells in thyroid hormone-deprived conditions. Stem Cells Int 2019:5496891","journal-title":"Stem Cells Int"},{"key":"5290_CR180","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00108-020-00790-4","volume":"61","author":"KA Iwen","year":"2020","unstructured":"Iwen KA, Brabant G (2020) Thyroid hormone therapy in old age. Internist (Berl) 61:541\u2013548","journal-title":"Internist (Berl)"},{"key":"5290_CR181","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13171","volume":"34","author":"RI Zorrilla Veloz","year":"2022","unstructured":"Zorrilla Veloz RI, McKenzie T, Palacios BE, Hu J (2022) Nuclear hormone receptors in demyelinating diseases. J Neuroendocrinol 34:e13171","journal-title":"J Neuroendocrinol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05290-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05290-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05290-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:03:58Z","timestamp":1764461038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05290-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":181,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5290"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05290-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have read and understood your journal\u2019s policies, and we believe that neither the manuscript nor the study violates any of these.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"217"}}